These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7648647)
1. Nifedipine in ischemic heart disease. Kloner RA Circulation; 1995 Sep; 92(5):1074-8. PubMed ID: 7648647 [No Abstract] [Full Text] [Related]
2. Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation? Yusuf S Circulation; 1995 Sep; 92(5):1079-82. PubMed ID: 7648648 [No Abstract] [Full Text] [Related]
3. Nifedipine and mortality. Grave defects in the dossier. Opie LH; Messerli FH Circulation; 1995 Sep; 92(5):1068-73. PubMed ID: 7648646 [No Abstract] [Full Text] [Related]
12. [Treatment with nifedipine retard: increasing doses as a therapeutic method]. Lobos Berajano JM; Lahoz Rallo F; Seguido Aliaga P; Castellanos Maroto J; Robles Pérez R Rev Clin Esp; 1989 Jan; 184(1):47-9. PubMed ID: 2704870 [No Abstract] [Full Text] [Related]
13. Effects of a slow-release nifedipine on 24-hour ambulatory blood pressure and ischemic changes on 24-hour ambulatory electrocardiogram in patients with severe coronary artery disease. Matsumoto N; Ideishi M; Sasaguri M; Nii T; Nakashima Y; Arakawa K Cardiology; 2000; 94(1):36-43. PubMed ID: 11111143 [TBL] [Abstract][Full Text] [Related]
14. [Calcium channel blockers pharmacology and their use as tocolytics]. Bejan-Angoulvant T; Crochet J; Jonville-Bera AP J Gynecol Obstet Biol Reprod (Paris); 2015 Apr; 44(4):305-11. PubMed ID: 25728783 [TBL] [Abstract][Full Text] [Related]
15. Non-substitution of nifedipine slow-release preparations. Van Veenhuyzen D; Coetzee R S Afr Med J; 2002 Nov; 92(11):838, 840. PubMed ID: 12506575 [No Abstract] [Full Text] [Related]
16. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses. Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic differences between nifedipine capsule and GITS formulations in hypertensive patients. Isordia I; Carrasco M; Chávez-Negrete A; Palma-Aguirre JA; Flores-Murrieta FJ; Castañeda-Hernández G Int J Clin Pharmacol Ther; 1997 Mar; 35(3):133. PubMed ID: 9089004 [No Abstract] [Full Text] [Related]
19. Nifedipine XL-induced dysuria. Patil K; Tabibian JH; Lake M; Sisson S Am J Med; 2012 Sep; 125(9):e3-4. PubMed ID: 22682792 [No Abstract] [Full Text] [Related]
20. [Nifedipine in ischemic heart disease: a ban on its use or a differential approach to therapy?]. Martsevich SIu Ter Arkh; 1996; 68(9):31-5. PubMed ID: 9005608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]